🔎 Trials Near Me

Beranda › Depresi Resistensi Terapi › Maryland

Uji klinis Depresi Resistensi Terapi di Maryland

6 studi untuk Depresi Resistensi Terapi mencari peserta di lokasi di Maryland.

Kota di Maryland

Teks studi resmi (Bahasa Inggris)

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

  • National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT06511908

Long-term Observation of Participants With Mood Disorders

  • National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT04877977

Natural History of Depression, Bipolar Disorder and Suicide Risk

  • National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasional
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06462196

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

  • Sheppard Pratt Health System, Inc., Baltimore
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jun 2026 · NCT03887715

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

  • Sheppard Pratt, Baltimore
  • Sunstone Medical, PC, Rockville
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT06524830

ALTO-207 in Adults With Treatment-resistant Depression (TRD)

  • Site 7151, Annapolis
  • Site 7054, Pikesville
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Apr 2026 · NCT07553637

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.